Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...

From Hollywood celebrities to powerful politicians like Boris Johnson, the Ozempic craze has exploded across the world. Promoted as a miracle weight-loss solution, the drug has also sparked growing ...

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth ...

CBS News legal contributor Jessica Levinson breaks down the ruling. The Trump administration's push for FDA approval of fruit ...

Foundayo (orforglipron) is an oral medication approved by the FDA in April 2026 for weight management in adults with obesity or overweight plus weight-related conditions. Unlike other oral GLP-1 ...

The Trump administration has placed additional sanctions on Iran as part of a sprawling economic pressure campaign during the ...

Israel’s air force targeted sites belonging to Hezbollah in Lebanon, including in the country’s eastern Bekaa Valley, late on ...

Former Netflix CFO and Hims board member David Wells bought 48,400 shares worth about $1.17 million. ・Investor concerns intensified after Hims reported weak Q1 results that missed revenue and earnings ...

As GLP-1 medications continue to evolve and become more popular, they’re having both a major moment and impact in the health ...

A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...